EMERPHED® (ephedrine sulfate) RTU injection is the first ready-to-use product in its category, eliminating the need for compounding or diluting and mixing in the operating room. With a slightly higher price tag than compounding products, we focused on EMERPHED’s differentiators, providing clear benefits to adoption: simple, stable, safe.


Small copy blocks told the story in a simple, straightforward way.
Carousel imagery shifted to highlight the 3 differentiators.

Journal Ads

This series of journal ads targeted key audiences including hospital P&T committees,
anesthesiologists, CRNAs, and clinical pharmacists.

Awards won:

2020: Gold, Davey; Platinum, MarCom